1. Assessment of the Pharmacokinetics, Pharmacodynamics, and Safety of Single Doses of TV‐1106, a Long‐Acting Growth Hormone, in Healthy Japanese and Caucasian Subjects. Issue 4 (21st September 2016) Authors: Cohen‐Barak, Orit; Barkay, Hadas; Rasamoelisolo, Michele; Butler, Kathleen; Yamada, Kazumasa; Bassan, Merav; Yoon, Esther; Spiegelstein, Ofer Journal: Clinical pharmacology in drug development Issue: Volume 6:Issue 4(2017) Page Start: 331 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Effect of ruxolitinib cream on achievement of VASI50 by body region: Week 52 pooled analysis of the TRuE-V phase 3 studies. (18th January 2023) Authors: Passeron, Thierry; Harris, John E; Pandya, Amit G; Seneschal, Julien; Grimes, Pearl; Kornacki, Deanna; Wang, Mingyue; Butler, Kathleen; Ezzedine, Khaled; Rosmarin, David Journal: British journal of dermatology Issue: Volume 188(2023)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Effect of the CYP3A inhibitors, diltiazem and ketoconazole, on ticagrelor pharmacokinetics in healthy volunteers. (23rd April 2013) Authors: Teng, Renli; Butler, Kathleen Journal: Journal of drug assessment Issue: Volume 2(2013) Page Start: 30 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Effect of the CYP3A inhibitors, diltiazem and ketoconazole, on ticagrelor pharmacokinetics in healthy volunteers. (2nd April 2013) Authors: Teng, Renli; Butler, Kathleen Journal: Journal of drug assessment Issue: Volume 2(2013) Page Start: 30 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Effect of ticagrelor on pulmonary function in healthy elderly volunteers and asthma or chronic obstructive pulmonary disease patients. (May 2013) Authors: Butler, Kathleen; Maya, Juan; Teng, Renli Journal: Current medical research and opinion Issue: Volume 29:Number 5(2013:May) Page Start: 569 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Efficacy and safety of ruxolitinib cream for the treatment of vitiligo by patient demographics and baseline clinical characteristics: Week 52 pooled subgroup analysis from two randomized phase 3 studies. (18th January 2023) Authors: Seneschal, Julien; Wolkerstorfer, Albert; Desai, Seemal R; Grimes, Pearl; Ezzedine, Khaled; Kornacki, Deanna; Wei, Shaoceng; Butler, Kathleen; Rosmarin, David Journal: British journal of dermatology Issue: Volume 188(2023)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Ruxolitinib cream for the treatment of vitiligo – Authors' reply. Issue 10264 (28th November 2020) Authors: Rosmarin, David; Butler, Kathleen; Kuo, Fiona; Harris, John E Journal: Lancet Issue: Volume 396:Issue 10264(2020) Page Start: 1736 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Ruxolitinib cream for treatment of vitiligo: a randomised, controlled, phase 2 trial. Issue 10244 (11th July 2020) Authors: Rosmarin, David; Pandya, Amit G; Lebwohl, Mark; Grimes, Pearl; Hamzavi, Iltefat; Gottlieb, Alice B; Butler, Kathleen; Kuo, Fiona; Sun, Kang; Ji, Tao; Howell, Michael D; Harris, John E Journal: Lancet Issue: Volume 396:Issue 10244(2020) Page Start: 110 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Safety, tolerability, and pharmacokinetics of multiple ascending doses of naloxegol. Issue 6 (4th September 2015) Authors: Eldon, Michael A.; Kugler, Alan R.; Medve, Robert A.; Bui, Khanh; Butler, Kathleen; Sostek, Mark Journal: Clinical pharmacology in drug development Issue: Volume 4:Issue 6(2015:Nov./Dec.) Page Start: 442 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Safety, tolerability, pharmacokinetics, and pharmacodynamic effects of naloxegol at peripheral and central nervous system receptors in healthy male subjects: A single ascending‐dose study. Issue 6 (4th September 2015) Authors: Eldon, Michael A.; Kugler, Alan R.; Medve, Robert A.; Bui, Khanh; Butler, Kathleen; Sostek, Mark Journal: Clinical pharmacology in drug development Issue: Volume 4:Issue 6(2015:Nov./Dec.) Page Start: 434 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗